Annual EBITDA
-$30.02 M
+$9.72 M+24.47%
December 31, 2023
Summary
- As of February 26, 2025, NRXP annual EBITDA is -$30.02 million, with the most recent change of +$9.72 million (+24.47%) on December 31, 2023.
- During the last 3 years, NRXP annual EBITDA has risen by +$21.69 million (+41.95%).
- NRXP annual EBITDA is now at all-time high.
Performance
NRXP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.62 M
+$6.28 M+79.47%
September 30, 2024
Summary
- As of February 26, 2025, NRXP quarterly EBITDA is -$1.62 million, with the most recent change of +$6.28 million (+79.47%) on September 30, 2024.
- Over the past year, NRXP quarterly EBITDA has increased by +$4.68 million (+74.26%).
- NRXP quarterly EBITDA is now -1646.76% below its all-time high of $104.80 thousand, reached on June 30, 2020.
Performance
NRXP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$20.07 M
+$4.40 M+17.98%
September 30, 2024
Summary
- As of February 26, 2025, NRXP TTM EBITDA is -$20.07 million, with the most recent change of +$4.40 million (+17.98%) on September 30, 2024.
- Over the past year, NRXP TTM EBITDA has increased by +$5.22 million (+20.64%).
- NRXP TTM EBITDA is now -19245.99% below its all-time high of $104.80 thousand, reached on June 30, 2020.
Performance
NRXP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NRXP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | +74.3% | +20.6% |
| 3 y3 years | +42.0% | +82.2% | +66.5% |
| 5 y5 years | +42.0% | +68.5% | -297.9% |
NRXP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.7% | at high | +94.7% | at high | +78.4% |
| 5 y | 5-year | at high | +67.7% | -1646.8% | +96.4% | <-9999.0% | +81.4% |
| alltime | all time | at high | +67.7% | -1646.8% | +96.4% | <-9999.0% | +81.4% |
NRx Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.62 M(-79.5%) | -$20.07 M(-18.0%) |
| Jun 2024 | - | -$7.90 M(+25.4%) | -$24.46 M(-3.2%) |
| Mar 2024 | - | -$6.30 M(+48.1%) | -$25.28 M(-15.8%) |
| Dec 2023 | -$30.02 M(-24.5%) | -$4.25 M(-29.4%) | -$30.02 M(-16.6%) |
| Sep 2023 | - | -$6.02 M(-30.9%) | -$36.02 M(-7.8%) |
| Jun 2023 | - | -$8.72 M(-21.0%) | -$39.08 M(+4.6%) |
| Mar 2023 | - | -$11.04 M(+7.8%) | -$37.34 M(-6.1%) |
| Dec 2022 | -$39.75 M | -$10.24 M(+12.8%) | -$39.75 M(-33.7%) |
| Sep 2022 | - | -$9.08 M(+30.1%) | -$59.91 M(-31.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.98 M(-48.1%) | -$87.87 M(+8.5%) |
| Mar 2022 | - | -$13.44 M(-55.8%) | -$81.00 M(-12.9%) |
| Dec 2021 | -$93.04 M(+79.9%) | -$30.41 M(-17.9%) | -$93.04 M(-13.7%) |
| Sep 2021 | - | -$37.04 M(>+9900.0%) | -$107.76 M(+42.0%) |
| Jun 2021 | - | -$112.00 K(-99.6%) | -$75.87 M(+0.3%) |
| Mar 2021 | - | -$25.48 M(-43.5%) | -$75.65 M(+50.8%) |
| Dec 2020 | -$51.72 M | -$45.12 M(+776.5%) | -$50.17 M(+894.7%) |
| Sep 2020 | - | -$5.15 M(-5012.3%) | -$5.04 M(-4912.3%) |
| Jun 2020 | - | $104.80 K | $104.80 K |
FAQ
- What is NRx Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual EBITDA year-on-year change?
- What is NRx Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly EBITDA year-on-year change?
- What is NRx Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM EBITDA year-on-year change?
What is NRx Pharmaceuticals annual EBITDA?
The current annual EBITDA of NRXP is -$30.02 M
What is the all time high annual EBITDA for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual EBITDA is -$30.02 M
What is NRx Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, NRXP annual EBITDA has changed by +$9.72 M (+24.47%)
What is NRx Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of NRXP is -$1.62 M
What is the all time high quarterly EBITDA for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly EBITDA is $104.80 K
What is NRx Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, NRXP quarterly EBITDA has changed by +$4.68 M (+74.26%)
What is NRx Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of NRXP is -$20.07 M
What is the all time high TTM EBITDA for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM EBITDA is $104.80 K
What is NRx Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, NRXP TTM EBITDA has changed by +$5.22 M (+20.64%)